Inherent Biosciences

Salt Lake City, UT · Founded 2019 · Privately Held (backing)

Developer of an epigenetic medicine platform designed to tackle health issues by overhauling the trial-and-error methodology. Inherent Biosciences is based in Salt Lake City, UT and was founded in 2019. It was valued at $18.1 million at its early-stage round in Sep 2022, the last priced event on record. It has raised $9.8 million across 1 recorded round; the latest was a $1.5 million seed round in Aug 2022.

PMV mark · valuation
$18.1M
Oct 2026
Priced at
its early-stage round
Sep 2022
Total raised
$9.8M
Last round
Seed Round
Aug 2022
How much has Inherent Biosciences raised?
$9.8Macross 1 recorded rounds · Aug 2022 – Aug 2022

Most recently, Inherent Biosciences raised $1.5M in its Seed Round (Aug 2022).

Free account
More of Inherent Biosciences with a free account
  • ·The complete investor list: 18 names
  • ·Watch Inherent Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Inherent Biosciences round by round

1 rounds
Aug 2022Seed Round$1.5MSEC filing▮
12 investors participated

How much has Inherent Biosciences raised?

Inherent Biosciences has raised $9.8 million in total; 1 of its rounds is on record. The largest on record was a $1.5 million seed round in Aug 2022.

Inherent Biosciences has filed 1 Form D with the SEC, most recently in May 2023 ($1.5 million sold to 12 investors).

Inherent Biosciences investors

18 investors are on record for Inherent Biosciences, including US National Science Foundation, Endless Frontier Labs, Kickstart (US) and Cadron Capital Partners. The seed round in Aug 2022 drew 12 investors.

For fundraisers
Raising for a company like Inherent Biosciences?

18 investors have backed Inherent Biosciences.

See all 18 investors →

Frequently asked about Inherent Biosciences

How much has Inherent Biosciences raised?
Inherent Biosciences has raised $9.8M in total across 1 recorded funding rounds.
When was Inherent Biosciences's last funding round?
Inherent Biosciences's most recent recorded round was Seed Round in Aug 2022, raising $1.5M.